Center for Excellence in Drug Safety and Pharmacovigilance

  • ^NDX4739.37+5.28 - +0.11%
  • ^FTSE6730.72-22.21 - -0.33%
  • ^AORD5502.60-57.80 - -1.04%
  • ^AXJO5444.00-56.20 - -1.02%
  • SLXP+0 - +0%
  • AUDUSD=X0.7453
  • USDJPY=X113.5030
  • WP Stock Ticker

Drug Safety and Pharmacovigillance News

Posted by on Dec 26, 2012

Merck’s Phase III program for Tredaptive comes to an end secondary to both safety and efficiacy concerns. For more information click...

Read More

Regulatory

Posted by on Jun 9, 2012

FDA Drug Safety Communication: Safety review update of cancer drug Revlimid (lenalidomide) and risk of developing new types of malignancies The U.S. Food and Drug Administration...

Read More

Get Educated

Posted by on Dec 26, 2012

Check our PV Education Page for more...

Read More

Publication Updates

Posted by on Dec 26, 2012

Several new pharmacovigilance publications have become available through Dec 2012. Check out the most recent articles references with links to stay on top of the most up to date PV...

Read More